Literature DB >> 18210339

Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.

Y D Park1, Y J Chung, H Y Chung, W Yu, H I Bae, S W Jeon, C M Cho, W Y Tak, Y O Kweon.   

Abstract

BACKGROUND AND AIM: Endoscopic mucosal resection (EMR) is currently not accepted as an alternative treatment to surgery in early gastric cancer (EGC) of the undifferentiated histologic type. The present retrospective analysis examined the correlation of various histologic factors with the presence of lymph node metastasis (LNM). PATIENTS AND METHODS: A retrospective analysis on 234 patients with poorly differentiated EGC who underwent radical gastrectomy with D2 lymph node dissection was undertaken. Several clinicopathologic factors were investigated to identify predictive factors for LNM: age, sex, type of operation, tumor location, tumor size, gross type, ulceration, lymphatic invasion, and depth of invasion.
RESULTS: Of the 234 lesions with poorly differentiated EGC, half (n = 116) already showed submucosal invasion in the resection specimen; 25.9 % of those (30/116) were limited to the upper third (SM1). Of the lesions confined to the mucosa, LNM was found in 3.4 % (4/118). With minor submucosal infiltration (SM1), the LNM rate was lower (0/30) in our patient population. Only with SM2/3 infiltration did the LNM rate sharply rise to around 30 %. The cut-off for submucosal infiltration depth was 500 microm (0/32 LNM), above which LNM rates were substantial (31.2 %; 24/77). There was limited correlation between the SM1-3 classification and actual measurement of submucosal infiltration depth. In a multivariate analysis, tumor size ( P = 0.033), depth of invasion ( P = 0.004), and lymphatic invasion ( P < 0.001) were associated with LNM.
CONCLUSION: Poorly differentiated EGC confined to the mucosa or with minimal submucosal infiltration (<or= 500 microm) could be considered for curative EMR due to the low risk of LNM. Given the limited case number of subgroups, these findings should be confirmed by more data from other centers, which should also focus on local recurrence after EMR in poorly differentiated EGC.

Entities:  

Mesh:

Year:  2008        PMID: 18210339     DOI: 10.1055/s-2007-966750

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  62 in total

1.  Feasible endoscopic therapy for early gastric cancer.

Authors:  Tian-Jiao Guo; Jin-Yu Qin; Lin-Lin Zhu; Jin Wang; Jin-Lin Yang; Yi-Ping Wang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

2.  Diagnostic accuracy of demarcation of undifferentiated-type early gastric cancer after Helicobacter pylori eradication.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Masami Omae; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Hiroshi Takahashi
Journal:  J Gastroenterol       Date:  2017-01-12       Impact factor: 7.527

3.  Predictive factors for lymph node metastasis in poorly differentiated early gastric cancer and their impact on the surgical strategy.

Authors:  Hua Li; Ping Lu; Yang Lu; Cai-Gang Liu; Hui-Mian Xu; Shu-Bao Wang; Jun-Qing Chen
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

4.  Predictive factors for lymph node metastasis in early gastric cancer.

Authors:  Chang-Mu Sung; Chen-Ming Hsu; Jun-Te Hsu; Ta-Sen Yeh; Chun-Jung Lin; Tse-Ching Chen; Ming-Yao Su; Cheng-Tang Chiu
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

5.  Can an intramucosal undifferentiated-type gastric cancer become a candidate for endoscopic submucosal resection?

Authors:  Seigo Kitano
Journal:  Gastric Cancer       Date:  2009       Impact factor: 7.370

6.  Do we have enough evidence for expanding the indications of ESD for EGC?

Authors:  Hang Lak Lee; Chang Hwan Choi; Dae Young Cheung
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

7.  Current status of endoscopic submucosal dissection for the management of early gastric cancer: a Korean perspective.

Authors:  Hoon Jai Chun; Bora Keum; Ji Hyun Kim; Sang Young Seol
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

8.  Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancer for magnifying endoscopy with narrow-band imaging: surgical cases.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Tomoki Shimizu; Masami Omae; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Masahiro Igarashi; Hiroshi Takahashi
Journal:  Surg Endosc       Date:  2016-08-29       Impact factor: 4.584

9.  Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer.

Authors:  Ik-Chan Song; Zhe-Long Liang; Jung-Chan Lee; Song-Mei Huang; Ha-Yon Kim; Yoon-Suk Oh; Hwan-Jung Yun; Ji-Young Sul; Deog-Yeon Jo; Samyong Kim; Jin-Man Kim; Hyo-Jin Lee
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

10.  Identification of clinicopathological factors predicting lymph node metastasis in differentiated submucosal gastric cancer: Impact on surgical strategy.

Authors:  Zhi-Bin Huo; Shuo-Po Chen; Hua Li
Journal:  Oncol Lett       Date:  2012-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.